Back

Engineering a novel adenoviral vector for targeted gene delivery to cardiomyocytes

11 June 2026 (12:23 - 12:26)
Organised by: Logo
Seminar Presentation Part of: Module B: Mentoring & how-to sessions - Poster rapid fire session 1 Gene Therapy, Cell Therapy Open Access Basic Science Course 2026 ESC Fund

About the speaker

Photo
Doctor Shuai Guo

Institute for Neuroscience and Cardiovascular Research, Edinburgh (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Identification of novel epigenetic modulators regulating cardiomyocyte differentiation
Doctor A. Aljagthmi (SA)
Presentation thumbnail
Crosstalk between circulating DPP3 and immune cells in the context of cardio-systemic stress
Doctor N. Assad (Paris, FR)
Presentation thumbnail
Multi-omics and liquid biopsy approaches for early detection and mechanistic characterization of cancer therapy-related cardiac dysfunction
Doctor M. Camilli (Rome, IT)
Presentation thumbnail
Molecular antagonism between interleukin-6 and the S100A8/A9 heterodimer in the genesis of atrial fibrillation following ST-elevation myocardial infarction: implications for personalised medicine
Mr D. Cozac (Targu Mures, RO)
Presentation thumbnail
Innate-adaptive immune interactions in arrhythmogenic cardiomyopathy
Doctor N. Fabin (Milan, IT)

Access the full session

Session thumbnail
Module B: Mentoring & how-to sessions - Poster rapid fire session 1

The Event

Event poster

Basic Science Course 2026

11 June 2026 12:23 CET
You may be interested in
thumbnail
Congress Presentation
ASE: Young Investigator Awardee presentation: "Cavitation-facilitated augmentation of myocyte gene delivery with adeno-associated Vector-9: a bioengineering strategy to address clinical gaps in cardiac gene therapy"
11 December 2025
thumbnail
Congress Presentation
Towards advanced cardiac miRNA therapies through DNA-based nanostructures
29 April 2022
thumbnail
Congress Presentation
Adeno-associated virus (AAV) 6 provides efficient gene transfer upon intramyocardial injection in vivo
12 April 2024
thumbnail
Congress Presentation
EDEM2 is new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources